SOPH today
$8.05+$0.19 (+2.42%)close Nov 13, 2026Trend
DailyUptrend (starting)
4 hourStrong Bearish
1 hourStrong Bullish
15 minExpanding
5 minSymmetric Triangle
Daily trend turns down below $6.39
Key levels
Resistance$8.73
Support$7.98
Support$6.90
Latest news & SEC filings
SEC FilingSophia Genetics Sa filed an insider trading report (Form 4)
EarningsSOPHiA GENETICS Posts Q3 2026 Results
EarningsSophia Genetics holds Q3 2026 earnings call
All SOPH news →About SOPHiA GENETICS
SOPHiA GENETICS provides a data-driven medicine platform, SOPHiA DDM, used for genomic and multimodal analysis. Its applications and services support hospitals, laboratories, researchers, and medical personnel in disease diagnosis and research. The company operates in Europe and the United States, offering both research-use-only and CE-IVD marked products.
Based on the company's 20-F filed Mar 3, 2026.
Nasdaq · Technology
SOPHiA GENETICS SA (SOPH)
What Is the Price Target for SOPH?
SEPT Low Target
$9.00
SEPT Mid Target
$13.00
SEPT High Target
$14.00
Analyst Consensus
$13.00
Is SOPH a Buy or Sell Right Now?
Thesis
- •Revenue growing 18.6% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for SOPH.
Start Free Trial →Is SOPH Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$13.00
33
Moat Score
NONE
2/9
Piotroski Score
-2.4
Altman Z-Score
What Is Smart Money Doing with SOPH?
Insider Signal
SELLING
1 buys / 19 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| HIBBS KATHY L | director | Sale | 6,250 | $48K | Nov 10, 2026 |
| Camblong Jurgi | director officer | Sale | 8,500 | $66K | Nov 10, 2026 |
| Van Well Daan | officer | Sale | 1,411 | $10K | Nov 9, 2026 |
| CARDOZA GEORGE | officer | Buy | 20,000 | $141K | Nov 6, 2026 |
| Xu Zhenyu | officer | Sale | 4,000 | $29K | Oct 13, 2026 |
| Menu Philippe | officer | Sale | 5,000 | $36K | Oct 12, 2026 |
| Camblong Jurgi | director officer | Sale | 8,500 | $62K | Oct 12, 2026 |
| CARDOZA GEORGE | officer | Sale | 1,592 | $13K | Oct 5, 2026 |
| Van Well Daan | officer | Sale | 6,168 | $50K | Oct 5, 2026 |
| Valente Manuela | officer | Sale | 4,240 | $34K | Oct 5, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →SOPH Growth Story
Revenue YoY
18.6%
3yr Revenue CAGR
17.6%
EPS Growth YoY
-23.16%
FCF Growth YoY
18.5%
Revenue Trend
STRONG
Dark Pool Trades for SOPH
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for SOPH, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 18:24:39 | $7.94 | 2,500 | $$20K | BUY |
| 17:50:56 | $7.92 | 4,128 | $$33K | BUY |
| 17:09:06 | $7.81 | 5,000 | $$39K | BUY |
| 17:01:58 | $7.79 | 5,000 | $$39K | BUY |
| 16:21:28 | $7.70 | 1,172 | $$9K | SELL |
5 dark pool trades shown · $$140K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for SOPH
PREVIEWSEPT Investing provides real-time options flow tracking for SOPH, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $5 | Jun 17 | 216 | $$35.0K | 100 | BLOCK |
1 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for SOPHiA GENETICS SA (SOPH) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →SOPH — frequently asked questions
What is SOPH stock price today?
SOPHiA GENETICS SA (SOPH) is at $8.05, up 2.42% (+$0.19) at the Nov 13, 2026 close.
Why is SOPH stock moving today?
Latest SOPH news — Nov 9, 2026: Sophia Genetics Sa filed an insider trading report (Form 4) · Nov 3, 2026: SOPHiA GENETICS Posts Q3 2026 Results
What is the SOPH price target?
The average analyst price target for SOPH is $13.00, ranging from $9 to $14, based on 4 analysts.
What do analysts rate SOPH?
Analyst ratings for SOPH: 0 Buy, 8 Hold, 0 Sell — consensus Hold.
Did SOPH beat earnings?
SOPH last reported on Aug 4, 2026: EPS -$0.26 vs -$0.21 expected — a miss of 23.8%.
Does SOPH pay a dividend?
SOPH does not currently pay a dividend.
What are SOPH support and resistance levels?
Support: $7.98, $6.90, $5.92. Resistance: $8.73.
What are insiders doing with SOPH?
Insider activity: SELLING, 1 buys and 19 sells in the last 90 days.
What is the latest news on SOPH?
Nov 9, 2026: Sophia Genetics Sa filed an insider trading report (Form 4) · Nov 3, 2026: SOPHiA GENETICS Posts Q3 2026 Results · Nov 3, 2026: Sophia Genetics holds Q3 2026 earnings call